A Phase I Study of Pegylated Arginine Deiminase (Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-grade Glioma

Peter E. Hall(Barts Health NHS Trust), Peter W. Szlosarek(St Bartholomew's Hospital), John S. Bomalaski(Polaris (United States)), Sarah Jefferies(Addenbrooke's Hospital), Simon Pacey(Royal Marsden NHS Foundation Trust), Tomasz Matys(Cambridge University Hospitals NHS Foundation Trust), Bor-Wen Wu(Polaris (United States)), Matthew Williams(Charing Cross Hospital), Nelofer Syed(Hammersmith Hospital), Fiona Harris(Cambridge University Hospitals NHS Foundation Trust), Timothy Crook(Royal Surrey County Hospital), R. Jena(University of Cambridge), Stephen Ellis(Barts Health NHS Trust), Richard Shaffer(Bupa Cromwell Hospital), Michael Sheaff(Moorfields Eye Hospital NHS Foundation Trust), Ramsay S. Khadeir(Queen Mary University of London), Dimitris Paraskevopoulos(Barts Health NHS Trust), Xiaoxing Feng(Polaris (United States)), Amanda Johnston(Polaris (United States)), Jane Evanson(Barts Health NHS Trust), P N Plowman(St Bartholomew's Hospital), Rachel Lewis(St Bartholomew's Hospital), J. A. Thomson, Kevin O’Neill(Imperial College Healthcare NHS Trust), K.M. Smith(Barts Health NHS Trust)
Clinical Cancer Research
February 22, 2019
Cited by 70


Related Papers